Conditions: B Acute Lymphoblastic Leukemia; CD19 Positive; Minimal Residual Disease; Philadelphia Chromosome Positive
Interventions: Biological: Chimeric Antigen Receptor T-Cell Therapy; Drug: Cyclophosphamide; Drug: Fludarabine Phosphate; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration; Drug: NKTR-255
Sponsors: Crystal Mackall, MD; California Institute for Regenerative Medicine (CIRM)
Active, not recruiting